(Q37030617)

17 August 2017

Does acromegaly enhance mortality? (English)

1 reference

17 August 2017

John Ayuk

1

1 reference

PubMed ID

18075787

17 August 2017

Michael C Sheppard

series ordinal

2

1 reference

17 August 2017

1 March 2008

1 reference

Reviews in Endocrine and Metabolic Disorders

17 August 2017

1 reference

17 August 2017

9

1 reference

17 August 2017

1

1 reference

17 August 2017

33-39

1 reference

https://scigraph.springernature.com/pub.10.1007/s11154-007-9067-8

17 August 2017

0 references

cites work

Acromegaly: an epidemiological study

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11154-007-9067-8

Diagnosis and treatment of acromegaly complications.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11154-007-9067-8

Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions

21 January 2018

1 reference

12 December 2020

Consensus statement: medical management of acromegaly

1 reference

12 December 2020

Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly.

1 reference

12 December 2020

Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy.

1 reference

12 December 2020

Determinants of clinical outcome and survival in acromegaly

1 reference

12 December 2020

Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly

1 reference

12 December 2020

Incidence of cerebral infarction after radiotherapy for pituitary adenoma

1 reference

12 December 2020

Radiotherapy in acromegaly: the argument against

1 reference

12 December 2020

Radiotherapy in acromegaly: a protagonists viewpoint

1 reference

12 December 2020

Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly

1 reference

12 December 2020

Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984

1 reference

12 December 2020

Current treatment guidelines for acromegaly

1 reference

12 December 2020

Premature mortality due to cardiovascular disease in hypopituitarism

1 reference

12 December 2020

Long-term treatment outcome in acromegaly

1 reference

12 December 2020

Cerebrovascular mortality in patients with pituitary adenoma

1 reference

12 December 2020

Pathogenesis and prevalence of hypertension in acromegaly

1 reference

12 December 2020

Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly

1 reference

12 December 2020

Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results

1 reference

12 December 2020

Increased cerebrovascular mortality in patients with hypopituitarism

1 reference

12 December 2020

Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity.

1 reference

12 December 2020

A nationwide survey of mortality in acromegaly

1 reference

12 December 2020

Factors influencing mortality in acromegaly

1 reference

12 December 2020

Screening colonoscopy for acromegaly in perspective*

1 reference

12 December 2020

Effects of radiation on cerebral vasculature: a review

1 reference

12 December 2020

Epidemiology of acromegaly in the Newcastle region.

1 reference

12 December 2020

Acromegaly and colorectal cancer: a comprehensive review of epidemiology, biological mechanisms, and clinical implications

1 reference

12 December 2020

The somatomedin hypothesis: 2001.

1 reference

12 December 2020

The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas.

1 reference

12 December 2020

Assessment of GH status in acromegaly using serum growth hormone, serum insulin-like growth factor-1 and urinary growth hormone excretion.

1 reference

12 December 2020

Criteria for cure of acromegaly: a consensus statement

1 reference

12 December 2020

Colorectal screening guidelines in acromegaly

1 reference

12 December 2020

Acromegaly and cancer: not a problem?

1 reference

12 December 2020

Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group

1 reference

12 December 2020

Guidelines for acromegaly management

1 reference

12 December 2020

The effect of hypopituitarism on life expectancy

1 reference

12 December 2020

Mortality in acromegaly

1 reference

12 December 2020

Hypothalamic dysfunction in "cured" acromegaly is treatment modality dependent.

1 reference

12 December 2020

High incidence of cardiovascular disease and increased prevalence of cardiovascular risk factors in women with hypopituitarism not receiving growth hormone treatment: preliminary results

1 reference

12 December 2020

Determinants of survival in treated acromegaly in a single center: predictive value of serial insulin-like growth factor I measurements

1 reference

12 December 2020

The role of growth hormone/insulin-like growth factors in adipocyte differentiation

1 reference

12 December 2020

Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA).

1 reference

12 December 2020

Acromegaly and gastrointestinal cancer

1 reference

12 December 2020

Colorectal neoplasia in acromegaly

1 reference

12 December 2020

Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group.

1 reference

12 December 2020

An audit of outcome of treatment in acromegaly.

1 reference

12 December 2020

1 reference

12 December 2020

10.1007/S11154-007-9067-8

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

18075787